Neoplasm Metastasis: all 3,564 studies
Page 19 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- A Study of ART4215 for the Treatment of Advanced or Metastatic Solid TumorsCompletedNCT04991480Phase 1
- Dose Efficiency of Modern CT Scanners in Oncologic ScansStatus unknownNCT04989192Not applicable
- the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung CancerStatus unknownNCT04978753Phase 2
- Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)TerminatedNCT04975256Phase 1
- Value of Information of Secondary dAta in ONCOGEneticsStatus unknownNCT04972409
- Phase 1 Trial for Tumor Treating Field for Drug/Radiation Resistant Brain MetastasesStatus unknownNCT04967027Early Phase 1
- Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Active, not recruitingNCT04964934Phase 3
- Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their SpousesActive, not recruitingNCT04960787Not applicable
- Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 ExpressionActive, not recruitingNCT04957615Phase 2
- Axillary Lymph Node Tattoo Marking StudyTerminatedNCT04947917Not applicable
- Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal MetastasisStatus unknownNCT04944069Not applicable
- Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of CancerCompletedNCT04941872Not applicable
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedNCT04931823Phase 1
- Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid LevelsWithdrawnNCT04931420Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT04913662Phase 1
- Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver MetastasisStatus unknownNCT04912258Phase 3
- A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma PatientsCompletedNCT04911998
- Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLCStatus unknownNCT04905550Phase 2
- QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT04898543Phase 1
- Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic CancerStatus unknownNCT04897854Phase 3
- Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic TrialCompletedNCT04896099
- Radiosurgery Before Surgery for the Treatment of Brain MetastasesCompletedNCT04895592Early Phase 1
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)Active, not recruitingNCT04895358Phase 3
- Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional StudyTerminatedNCT04895202
- Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsTerminatedNCT04892017Phase 1
- Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain MetastasesWithdrawnNCT04889066Phase 2
- Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary MetastasesCompletedNCT04887298Phase 1/2
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Active, not recruitingNCT04886804Phase 1
- FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal MetastasisStatus unknownNCT04886193Not applicable
- Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.CompletedNCT04881045Phase 1
- Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced SarcomaActive, not recruitingNCT04874311Phase 2
- Cemiplimab for Secondary AngiosarcomasCompletedNCT04873375Phase 2
- Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic CancerNo longer availableNCT04869501
- Study of Cabozantinib Plus TAS102 in mCRC as Salvage TherapyCompletedNCT04868773Phase 1
- A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT04866134Phase 1/2
- Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT04862260Early Phase 1
- Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid TumorsStatus unknownNCT04859569Phase 3
- Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast CancerWithdrawnNCT04856475Phase 2
- 68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)Status unknownNCT04849247Phase 1
- Radiographic Evaluation of Secondary Alveolar Bone Grafting in Patients With Alveolar CleftCompletedNCT04845308
- Ex Vivo Intraarterial Methylene Blue Injection Improve Nodal Staging Accuracy in Colorectal CancerCompletedNCT04842968Not applicable
- Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid TumorsSuspendedNCT04840589Phase 1
- Detection and Automatic Segmentation of Liver Nodules in Patients With Colorectal AdenocarcinomaStatus unknownNCT04834596
- Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung CancerStatus unknownNCT04833205Phase 2
- Sequence of Radiation and Targeted Therapy in Brain MetastasesCompletedNCT04832672
- Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver MetastasesStatus unknownNCT04832204Phase 2
- ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)Active, not recruitingNCT04829604Phase 2
- Keynatinib in Treated Patients with NSCLC and Brain MetastasesCompletedNCT04824079Phase 2
- The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After StrokeCompletedNCT04821518
- Perception of Cure Among Patients With Metastatic CancerWithdrawnNCT04820894
- Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot StudyStatus unknownNCT04817813
- A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With LarotrectinibCompletedNCT04814667
- Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid TumorsCompletedNCT04812509Phase 3
- NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic CancersStatus unknownNCT04808531Phase 3
- Targeting ATR in Soft-tissue SarcomasCompletedNCT04807816Phase 2
- Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain MetastasesStatus unknownNCT04801342Phase 2
- A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid TumorsTerminatedNCT04799054Phase 1/2
- Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)Status unknownNCT04793061
- Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell CarcinomaActive, not recruitingNCT04792073Phase 2
- Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer PatientsCompletedNCT04790968Not applicable
- Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerActive, not recruitingNCT04787744Phase 2/3
- Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain MetastasesStatus unknownNCT04787185
- Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic RadiosurgeryActive, not recruitingNCT04785521
- Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesTerminatedNCT04785287Phase 1/2
- Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)Active, not recruitingNCT04784715Phase 3
- A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)Status unknownNCT04778800Not applicable
- Impact of Thermotherapy During Childbirth on Postpartum Perineal Pain (PERISAFE)CompletedNCT04778631Not applicable
- Predicting Disease Progression and/or Recurrence in CancerCompletedNCT04776837
- Randomized Clinical Trial of a Multi-Modal Palliative Care InterventionCompletedNCT04773639Not applicable
- Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant MetastasisStatus unknownNCT04769908Phase 2
- Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic DiseaseWithdrawnNCT04765423Not applicable
- Mirtazapine in Cancer-related Poly-symptomatologyTerminatedNCT04763135Phase 3
- 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver MetastasesStatus unknownNCT04755907
- Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)Active, not recruitingNCT04751773Not applicable
- Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical TreatmentCompletedNCT04744688
- Metastatic Solid Cancer Clinical TrialActive, not recruitingNCT04739618Phase 2
- Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast CancerCompletedNCT04729647Not applicable
- A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsTerminatedNCT04725331Phase 1/2
- Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)Status unknownNCT04720391
- DNX-2440 for Resectable Colorectal Liver MetastasisSuspendedNCT04714983Phase 1
- A Phase 2 Trial for Patients With Metastatic Solid CancerActive, not recruitingNCT04713371Phase 2
- Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ CancersActive, not recruitingNCT04713046Phase 1/2
- A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseActive, not recruitingNCT04711252Phase 3
- A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic CancersStatus unknownNCT04710290Phase 2/3
- Dose Escalation Trial of BNT152+153 in Patients With CancerCompletedNCT04710043Phase 1
- LAG3 PET Imaging in Advanced Solid TumorsActive, not recruitingNCT04706715Phase 1/2
- CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapyStatus unknownNCT04704960
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialActive, not recruitingNCT04704661Phase 1
- Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal CancerTerminatedNCT04701281Phase 1/2
- Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationActive, not recruitingNCT04699188Phase 1/2
- Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cmStatus unknownNCT04686942
- Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic CancersActive, not recruitingNCT04682847
- Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver MetastasesCompletedNCT04682665
- Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICCWithdrawnNCT04682249Phase 2
- Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid TumorsCompletedNCT04678921Phase 1
- Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard TherapyCompletedNCT04676633Phase 1
- HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung CancerActive, not recruitingNCT04676477Phase 1
- Central Nervous System(CNS) Efficacy of DacomitinibStatus unknownNCT04675008Phase 2
- To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550TerminatedNCT04674748Phase 1
- Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04673448Phase 1